Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong · Delayed Price · Currency is HKD 5.34
+0.09 (1.71%)
Aug 27, 2026, 1:56 PM HKT
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.26 billion as of August 27, 2026. Its market cap has decreased by -64.00% in one year.
Market Cap
1.26B
Enterprise Value
718.39M
Revenue
1.50B
Ranking
n/a
PE Ratio
7.95
Stock Price
5.34
ChartMarket Cap Chart
Since November 28, 2024, HKG:2566's market cap has decreased from 1.88B to 1.26B, a decrease of -32.70%. That is a compound annual growth rate of -20.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 1.26B | -31.90% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.86B |
| Guangzhou Innogen Pharmaceutical Group | 1.84B |
| Mabpharm | 1.77B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.53B |
| SinoMab BioScience | 1.53B |
| Zhaoke Ophthalmology | 1.37B |
| Beijing Biostar Pharmaceuticals | 1.28B |
| CANbridge Pharmaceuticals | 1.09B |